Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Lindell

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
ERJ Open Research|October 27, 2022
Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosisGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
JAMA Internal Medicine|October 17, 2022
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher Carlsten, Kerri A Johannson, et al.
American Journal of Respiratory and Critical Care Medicine|December 25, 2012
Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognosesRehan A Kahloon, Jianmin Xue, Arpit Bhargava, et al.
Science Translational Medicine|October 4, 2013
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosisJose D Herazo-Maya, Imre Noth, Steven R Duncan, et al.
American Journal of Respiratory and Critical Care Medicine|May 16, 2015
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care UnitsGabriel T Bosslet, Thaddeus M Pope, Gordon D Rubenfeld, et al.
American Journal of Respiratory and Critical Care Medicine|July 20, 2021
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research StatementKerri I Aronson, Sonye K Danoff, Anne-Marie Russell, et al.
American Journal of Respiratory and Critical Care Medicine|June 20, 2025
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung DiseaseGillian C Goobie, Najmeh Assadinia, Chen Xi Yang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 22, 2021
Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated diseaseJonathan K Alder, Rachel M Sutton, Carlo J Iasella, et al.
JAMA|May 23, 2013
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosisAnna L Peljto, Yingze Zhang, Tasha E Fingerlin, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
ERJ Open Research|October 27, 2022
Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosisGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
JAMA Internal Medicine|October 17, 2022
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher Carlsten, Kerri A Johannson, et al.
American Journal of Respiratory and Critical Care Medicine|December 25, 2012
Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognosesRehan A Kahloon, Jianmin Xue, Arpit Bhargava, et al.
Science Translational Medicine|October 4, 2013
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosisJose D Herazo-Maya, Imre Noth, Steven R Duncan, et al.
American Journal of Respiratory and Critical Care Medicine|May 16, 2015
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care UnitsGabriel T Bosslet, Thaddeus M Pope, Gordon D Rubenfeld, et al.
American Journal of Respiratory and Critical Care Medicine|July 20, 2021
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research StatementKerri I Aronson, Sonye K Danoff, Anne-Marie Russell, et al.
American Journal of Respiratory and Critical Care Medicine|June 20, 2025
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung DiseaseGillian C Goobie, Najmeh Assadinia, Chen Xi Yang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 22, 2021
Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated diseaseJonathan K Alder, Rachel M Sutton, Carlo J Iasella, et al.
JAMA|May 23, 2013
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosisAnna L Peljto, Yingze Zhang, Tasha E Fingerlin, et al.
Pageof 10